286 Vaccine-boosted CAR T crosstalk with host immunity to reject tumors with antigen heterogeneity

Bibliographic Details
Main Author: Leyuan Ma
Format: Article
Language:English
Published: BMJ Publishing Group 2023-11-01
Series:Journal for ImmunoTherapy of Cancer
_version_ 1797630990620819456
author Leyuan Ma
author_facet Leyuan Ma
author_sort Leyuan Ma
collection DOAJ
first_indexed 2024-03-11T11:15:44Z
format Article
id doaj.art-ae40bf83e2cd4e558601eb6e54525f68
institution Directory Open Access Journal
issn 2051-1426
language English
last_indexed 2024-03-11T11:15:44Z
publishDate 2023-11-01
publisher BMJ Publishing Group
record_format Article
series Journal for ImmunoTherapy of Cancer
spelling doaj.art-ae40bf83e2cd4e558601eb6e54525f682023-11-11T05:20:08ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.0286286 Vaccine-boosted CAR T crosstalk with host immunity to reject tumors with antigen heterogeneityLeyuan Ma0Children’s Hospital of Philadelphia, Philadelphia, PA, USA
spellingShingle Leyuan Ma
286 Vaccine-boosted CAR T crosstalk with host immunity to reject tumors with antigen heterogeneity
Journal for ImmunoTherapy of Cancer
title 286 Vaccine-boosted CAR T crosstalk with host immunity to reject tumors with antigen heterogeneity
title_full 286 Vaccine-boosted CAR T crosstalk with host immunity to reject tumors with antigen heterogeneity
title_fullStr 286 Vaccine-boosted CAR T crosstalk with host immunity to reject tumors with antigen heterogeneity
title_full_unstemmed 286 Vaccine-boosted CAR T crosstalk with host immunity to reject tumors with antigen heterogeneity
title_short 286 Vaccine-boosted CAR T crosstalk with host immunity to reject tumors with antigen heterogeneity
title_sort 286 vaccine boosted car t crosstalk with host immunity to reject tumors with antigen heterogeneity
work_keys_str_mv AT leyuanma 286vaccineboostedcartcrosstalkwithhostimmunitytorejecttumorswithantigenheterogeneity